お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1006158

再吸収性血管足場の世界市場:材料タイプ(金属ベースのBVS、ポリマーベースのBVS)、アプリケーション(冠動脈ステント、末梢動脈ステント)、エンドユーザー別の予測(2026年まで)- COVID-19の累積的影響

Resorbable Vascular Scaffold Market Research Report by Material Type, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.33円
再吸収性血管足場の世界市場:材料タイプ(金属ベースのBVS、ポリマーベースのBVS)、アプリケーション(冠動脈ステント、末梢動脈ステント)、エンドユーザー別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の再吸収性血管足場の市場規模は、2020年の3億4,716万米ドルから2025年末までに6億3,276万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の再吸収性血管足場市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、材料タイプ・アプリケーション・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • ステークホルダー

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査器具
    • 収集:データソース
    • 分析:データ解釈
    • 策定:データ検証
    • 発行:調査報告書
    • 繰り返し:レポートの更新
  • 調査の実施
    • 開始:調査プロセス
    • 計画:調査計画の策定
    • 実行:調査の実施
    • 検証:発見と分析
    • 発行:調査報告書
  • 調査の成果

第3章 エグゼクティブサマリー

  • 市場展望
  • 材料タイプ別市場の展望
  • アプリケーション別市場の展望
  • エンドユーザー別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 材料タイプ別市場

  • 金属ベースのBVS
  • ポリマーベースのBVS

第7章 アプリケーション別市場

  • 冠動脈ステント
  • 末梢動脈ステント

第8章 エンドユーザー別市場

  • 外来手術センター
  • 心臓センター
  • 病院

第9章 南北アメリカ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域市場

  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、パートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第13章 企業のユーザビリティプロファイル

  • 480 Biomedical Inc
  • Abbott Laboratories
  • Amaranth Medical, Inc.
  • AMG International
  • Arterial Remodeling Technologies
  • Biosensors International Group, Limited
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • Kyoto Medical Planning Co., Ltd.
  • LEPU medical technology co., ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • OrbusNeich
  • Qualimed
  • REVA Medical, Inc.
  • S3V Vascular Technologies Private Limited
  • Stentys SA
  • Svelte Medical Systems, Inc.

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
  • 連絡先の詳細
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2026
  • FIGURE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 16. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 18. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2020 VS 2026 (%)
  • FIGURE 23. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2026
  • FIGURE 25. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 26. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 27. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, 2018-2026 (USD MILLION)
  • FIGURE 28. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 29. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 32. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 34. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 35. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 36. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 37. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. CALIFORNIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. FLORIDA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. ILLINOIS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. NEW YORK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. OHIO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. PENNSYLVANIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. TEXAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 47. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 49. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 58. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 60. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 64. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 65. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 66. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: FPNV POSITIONING MATRIX
  • FIGURE 72. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 73. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY METAL BASED BVS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY POLYMER BASED BVS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CORONARY ARTERY STENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY PERIPHERAL ARTERY STENTS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY CARDIAC CENTERS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ARGENTINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. BRAZIL RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. CANADA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. MEXICO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CALIFORNIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. CALIFORNIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. CALIFORNIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. FLORIDA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. FLORIDA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. FLORIDA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. ILLINOIS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ILLINOIS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ILLINOIS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. NEW YORK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. NEW YORK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. NEW YORK RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. OHIO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. OHIO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. OHIO RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. PENNSYLVANIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. PENNSYLVANIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. PENNSYLVANIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. TEXAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. TEXAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. TEXAS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. CHINA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. INDIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDONESIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. JAPAN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. MALAYSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. PHILIPPINES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. SOUTH KOREA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. THAILAND RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. FRANCE RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. GERMANY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. ITALY RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. NETHERLANDS RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. QATAR RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. RUSSIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. SAUDI ARABIA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SOUTH AFRICA RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SPAIN RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. UNITED ARAB EMIRATES RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY MATERIAL TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED KINGDOM RESORBABLE VASCULAR SCAFFOLD MARKET SIZE, BY END USER, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: SCORES
  • TABLE 120. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: BUSINESS STRATEGY
  • TABLE 121. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: PRODUCT SATISFACTION
  • TABLE 122. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: RANKING
  • TABLE 123. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 124. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: SHARE, BY COMPANY, 2020
  • TABLE 125. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: MERGER & ACQUISITION
  • TABLE 126. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 127. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 128. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: INVESTMENT & FUNDING
  • TABLE 129. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 130. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: LICENSE & PRICING
  • TABLE 131. GLOBAL RESORBABLE VASCULAR SCAFFOLD MARKET: CONTACT DETAILS
目次
Product Code: MRR-035AB9C0DAAC

The Global Resorbable Vascular Scaffold Market size was estimated at USD 347.16 Million in 2020 and expected to reach USD 393.18 Million in 2021, at a Compound Annual Growth Rate (CAGR) 13.59% to reach USD 745.91 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Resorbable Vascular Scaffold to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Material Type, the Resorbable Vascular Scaffold Market was studied across Metal Based BVS and Polymer Based BVS.

Based on Application, the Resorbable Vascular Scaffold Market was studied across Coronary Artery Stents and Peripheral Artery Stents.

Based on End User, the Resorbable Vascular Scaffold Market was studied across Ambulatory Surgical Centers, Cardiac Centers, and Hospitals.

Based on Geography, the Resorbable Vascular Scaffold Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Resorbable Vascular Scaffold Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Resorbable Vascular Scaffold Market, including 480 Biomedical Inc, Abbott Laboratories, Amaranth Medical, Inc., AMG International, Arterial Remodeling Technologies, Biosensors International Group, Limited, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardionovum GmbH, Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., LEPU medical technology co., ltd., Medtronic plc, Meril Life Sciences Pvt. Ltd., OrbusNeich, Qualimed, REVA Medical, Inc., S3V Vascular Technologies Private Limited, Stentys SA, and Svelte Medical Systems, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Resorbable Vascular Scaffold Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Resorbable Vascular Scaffold Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Resorbable Vascular Scaffold Market?
  • 4. What is the competitive strategic window for opportunities in the Global Resorbable Vascular Scaffold Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Resorbable Vascular Scaffold Market?
  • 6. What is the market share of the leading vendors in the Global Resorbable Vascular Scaffold Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Resorbable Vascular Scaffold Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Material Type Outlook
  • 3.4. Application Outlook
  • 3.5. End User Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Risk of CAD and PAD in the geriatric population
      • 5.1.1.2. Number of clinical trials and development in pipeline
      • 5.1.1.3. Increasing prevalence of cardiovascular diseases
    • 5.1.2. Restraints
      • 5.1.2.1. Presence of alternative methods
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing funding for R&D of surgical procedures
      • 5.1.3.2. Inclination towards drug-eluting devices for angioplasty
    • 5.1.4. Challenges
      • 5.1.4.1. Product recall
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Resorbable Vascular Scaffold Market, by Material Type

  • 6.1. Introduction
  • 6.2. Metal Based BVS
  • 6.3. Polymer Based BVS

7. Resorbable Vascular Scaffold Market, by Application

  • 7.1. Introduction
  • 7.2. Coronary Artery Stents
  • 7.3. Peripheral Artery Stents

8. Resorbable Vascular Scaffold Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Cardiac Centers
  • 8.4. Hospitals

9. Americas Resorbable Vascular Scaffold Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Resorbable Vascular Scaffold Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Resorbable Vascular Scaffold Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. 480 Biomedical Inc
  • 13.2. Abbott Laboratories
  • 13.3. Amaranth Medical, Inc.
  • 13.4. AMG International
  • 13.5. Arterial Remodeling Technologies
  • 13.6. Biosensors International Group, Limited
  • 13.7. Biotronik SE & Co. KG
  • 13.8. Boston Scientific Corporation
  • 13.9. Cardionovum GmbH
  • 13.10. Elixir Medical Corporation
  • 13.11. Kyoto Medical Planning Co., Ltd.
  • 13.12. LEPU medical technology co., ltd.
  • 13.13. Medtronic plc
  • 13.14. Meril Life Sciences Pvt. Ltd.
  • 13.15. OrbusNeich
  • 13.16. Qualimed
  • 13.17. REVA Medical, Inc.
  • 13.18. S3V Vascular Technologies Private Limited
  • 13.19. Stentys SA
  • 13.20. Svelte Medical Systems, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.